The DOI matches its Crossref record; 32 of the 32 references it cites were found in a registry or an index.
Microarray analysis of altered sphingolipid metabolism reveals prognostic significance of sphingosine kinase 1 in breast cancer
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Liang, Z., Leung, B. P. L., & Melendez, A. J. (2006) · Journal of Cellular Physiology · doi:10.1002/jcp.20646 · Cited by 68
RetractedGene-expression profiles to predict distant metastasis of lymph-node-negative primary breast cancer
Wang, Y., Klijn, J. G., Zhang, Y., Sieuwerts, A. M., Look, M. P., Yang, F., Talantov, D., Timmermans, M., Meijer-van Gelder, M. E., Yu, J., et al. (2005) · The Lancet · doi:10.1016/s0140-6736(05)17947-1 · Cited by 2,846
Sotiriou, C., Wirapati, P., Loi, S., Harris, A., Fox, S., Smeds, J., Nordgren, H., Farmer, P., Praz, V., Haibe-Kains, B., et al. (2006) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/djj052 · Cited by 2,063
Miller, L. D., Smeds, J., George, J., Vega, V. B., Vergara, L., Ploner, A., Pawitan, Y., Hall, P., Klaar, S., Liu, E. T., et al. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0506230102 · Cited by 1,268
Biologically active sphingolipids in cancer pathogenesis and treatment
Ogretmen, B., & Hannun, Y. A. (2004) · Nature Reviews Cancer · doi:10.1038/nrc1411 · Cited by 1,213
Pawitan, Y., Bjöhle, J., Amler, L., Borg, A.-L., Egyhazi, S., Hall, P., Han, X., Holmberg, L., Huang, F., Klaar, S., et al. (2005) · Breast Cancer Research · doi:10.1186/bcr1325 · Cited by 831
Berry, D. A., Cirrincione, C., Henderson, I. C., Citron, M. L., Budman, D. R., Goldstein, L. J., Martino, S., Perez, E. A., Muss, H. B., Norton, L., et al. (2006) · JAMA · doi:10.1001/jama.295.14.1658 · Cited by 731
Discovery and evaluation of inhibitors of human sphingosine kinase.
French, K. J., Schrecengost, R. S., Lee, B. D., Zhuang, Y., Smith, S. N., Eberly, J. L., Yun, J. K., & Smith, C. D. (2003) · PubMed · Cited by 599
Foekens, J. A., Atkins, D., Zhang, Y., Sweep, F. C. G. J., Harbeck, N., Paradiso, A., Cufer, T., Sieuwerts, A. M., Talantov, D., Span, P. N., et al. (2006) · Journal of Clinical Oncology · doi:10.1200/jco.2005.03.9115 · Cited by 361
Sphingosine Kinase Type 2 Is a Putative BH3-only Protein That Induces Apoptosis
Liu, H., Toman, R. E., Goparaju, S. K., Maceyka, M., Nava, V. E., Sankala, H., Payne, S. G., Bektas, M., Ishii, I., Chun, J., et al. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m304455200 · Cited by 356
Accumulation of Glucosylceramides in Multidrug-resistant Cancer Cells
Lavie, Y., Cao, H.-T., Bursten, S. L., Giuliano, A. E., & Cabot, M. C. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.32.19530 · Cited by 340
Van Brocklyn, J. R., Jackson, C. A., Pearl, D. K., Kotur, M. S., Snyder, P. J., & Prior, T. W. (2005) · Journal of Neuropathology and Experimental Neurology · doi:10.1097/01.jnen.0000175329.59092.2c · Cited by 330
A house divided: Ceramide, sphingosine, and sphingosine-1-phosphate in programmed cell death
Taha, T. A., Mullen, T. D., & Obeid, L. M. (2006) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2006.10.018 · Cited by 307
Ceramide glycosylation potentiates cellular multidrug resistance
LIU, Y., HAN, T., GIULIANO, A. E., & CABOT, M. C. (2001) · The FASEB Journal · doi:10.1096/fj.00-0223com · Cited by 303
Modulation of multidrug resistance efflux pump activity to overcome chemoresistance in cancer
MODOK, S., MELLOR, H., & CALLAGHAN, R. (2006) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2006.01.009 · Cited by 242
Antitumor Activity of Sphingosine Kinase Inhibitors
French, K. J., Upson, J. J., Keller, S. N., Zhuang, Y., Yun, J. K., & Smith, C. D. (2006) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.106.101345 · Cited by 242
Sphingosine Kinase Type 1 Promotes Estrogen-Dependent Tumorigenesis of Breast Cancer MCF-7 Cells
Nava, V (2002) · Experimental Cell Research · doi:10.1006/excr.2002.5658 · Cited by 226
Sphingosine kinase 1 is up‐regulated in colon carcinogenesis
Kawamori, T., Osta, W., Johnson, K. R., Pettus, B. J., Bielawski, J., Tanaka, T., Wargovich, M. J., Reddy, B. S., Hannun, Y. A., Obeid, L. M., et al. (2006) · The FASEB Journal · doi:10.1096/fj.05-4331fje · Cited by 217
Gong, Y., Yan, K., Lin, F., Anderson, K., Sotiriou, C., Andre, F., Holmes, F. A., Valero, V., Booser, D., Pippen, J. E., et al. (2007) · The Lancet Oncology · doi:10.1016/s1470-2045(07)70042-6 · Cited by 195
Osada, M., Yatomi, Y., Ohmori, T., Ikeda, H., & Ozaki, Y. (2002) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(02)02671-2 · Cited by 190
Olivera, A., Urtz, N., Mizugishi, K., Yamashita, Y., Gilfillan, A. M., Furumoto, Y., Gu, H., Proia, R. L., Baumruker, T., & Rivera, J. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m508931200 · Cited by 138
Novel Ceramide Analogs as Potential Chemotherapeutic Agents in Breast Cancer
Struckhoff, A. P., Bittman, R., Burow, M. E., Clejan, S., Elliott, S. G., Hammond, T., Tang, Y., & Beckman, B. S. (2004) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.103.062760 · Cited by 130
Döll, F., Pfeilschifter, J. M., & Huwiler, A. (2005) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2005.12.001 · Cited by 106
Updates on functions of ceramide in chemotherapy-induced cell death and in multidrug resistance
Öğretmen, B., & Hannun, Y. A. (2001) · Drug Resistance Updates · doi:10.1054/drup.2001.0225 · Cited by 106
Zeng, G., Gao, L., Birklé, S., & Yu, R. K. (2000) · PubMed · Cited by 98
Manka, D. R., Spicer, Z., & Millhorn, D. E. (2005) · Cancer Research · doi:10.1158/0008-5472.can-05-3091 · Cited by 71
Huwiler, A., & Zangemeister‐Wittke, U. (2007) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2007.04.010 · Cited by 66
Sphingosine kinase-1 – a potential therapeutic target in cancer
Cuvillier, O. (2006) · Anti-Cancer Drugs · doi:10.1097/cad.0b013e328011334d · Cited by 52
Modlich, O., Prisack, H.-B., Munnes, M., Audretsch, W., & Bojar, H. (2005) · Journal of Translational Medicine · doi:10.1186/1479-5876-3-32 · Cited by 51
Modulation of P‐glycoprotein function by sphingosine kinase‐1 in brain endothelial cells
Pilorget, A., Demeule, M., Barakat, S., Marvaldi, J. L., Luis, J., & Béliveau, R. (2006) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2006.04295.x · Cited by 49
van der Hage, J. A., Mieog, J. S. D., van de Vijver, M. J., & van de Velde, C. J. (2007) · Breast Cancer Research · doi:10.1186/bcr1778 · Cited by 38
Molecular Mechanisms of GD3-Induced Apoptosis in U-1242 MG Glioma Cells
Omran, O. M., Saqr, H. E., & Yates, A. J. (2006) · Neurochemical Research · doi:10.1007/s11064-006-9147-2 · Cited by 10
Cited by
Sphingosine 1-phosphate and cancer
Pyne, N. J., & Pyne, S. (2010) · Nature Reviews Cancer · doi:10.1038/nrc2875 · Cited by 852
Levy, M., & Futerman, A. H. (2010) · IUBMB Life · doi:10.1002/iub.319 · Cited by 632
“whereas another study demonstrated that CerS6 expression was regulated in an estrogen receptor dependent manner (77), and CerS6 mRNA levels were elevated in breast cancer tissue (55, 56).”
BackgroundCeramide synthases at the centre of sphingolipid metabolism and biology
Mullen, T. D., Hannun, Y. A., & Obeid, L. M. (2012) · Biochemical Journal · doi:10.1042/bj20111626 · Cited by 539
Targeting the sphingosine-1-phosphate axis in cancer, inflammation and beyond
Kunkel, G. T., Maceyka, M., Milstien, S., & Spiegel, S. (2013) · Nature Reviews Drug Discovery · doi:10.1038/nrd4099 · Cited by 434
Nagahashi, M., Ramachandran, S., Kim, E. Y., Allegood, J. C., Rashid, O. M., Yamada, A., Zhao, R., Milstien, S., Zhou, H., Spiegel, S., et al. (2012) · Cancer Research · doi:10.1158/0008-5472.can-11-2167 · Cited by 315
Metadata
- Authors
- Ruckhäberle, E., Rody, A., Engels, K., Gaetje, R., von Minckwitz, G., Schiffmann, S., Grösch, S., Geisslinger, G., Holtrich, U., Karn, T., & Kaufmann, M.
- Venue
- Breast Cancer Research and Treatment
- Published
- 2007-12-04
- Volume
- 112
- Issue
- 1
- Pages
- 41-52
- ISSN
- 0167-6806 (ISSN-L)
- 1573-7217
- OpenAlex
- W1969996654
- Cited by
- 302
- References
- 32
- FWCI
- 7.30
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.